Sulfonylureas and biguanide antidiabetic combinations are a class of combination oral antidiabetic drug used to treat patients with type 1 or type 2 diabetes. Sulfonylureas lower glucose concentration in the blood by stimulating insulin secretion. Biguanides act against insulin resistance and are one of the primary diabetes treatments. Sulfonylureas and biguanide antidiabetic combinations are medications that incorporate both of these agents to provide more effective treatment. Commonly prescribed sulfonylureas and biguanide antidiabetic combinations include Glipizide-metformin (glipizide, metformin hydrochloride), Metaglip (glipizide, metformin hydrochloride), and Glucovance (metformin, glyburide).
Drugs classified as Sulfonylureas and Biguanide Antidiabetic Combinations are frequently used to treat the following conditions:
Click on a drug below in order to find information and discounted prices at pharmacies near you.